findmyKOL
Clinical trialNCT06023459CompletedPhase 3Interventional

Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)

SponsorYih-Ing HserEnrollment140Narcotic-Related DisordersOpioid-Related DisordersSubstance-Related Disorders
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Applegate Recovery El Dorado

    El Dorado, Arkansas, United States

  • Southern Humboldt Community Healthcare District - Jerold Phelps Community Hospital

    Garberville, California, United States

  • Gibson Area Hospital and Health Services - Gibson Recovery Optimizing Wellness

    Gibson City, Illinois, United States

  • Penobscot Community Health Care Inc. - Seaport Community Health Center

    Belfast, Maine, United States

  • Oregon Health & Science University Primary Care Clinic, Scappoose

    Scappoose, Oregon, United States

  • Providence Northeast Washington Medical Group

    Colville, Washington, United States

  • New Beginnings Recovery Clinic & Behavioral Health Center

    New Martinsville, West Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Oct 2024
Primary completion
4 Nov 2025
Completion
14 Jan 2026
Last update posted
29 Apr 2026
Registered enrollment
140
Registry id
NCT06023459

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.